Clinicians’ ability to detect abnormal eye-movements has powerful implications for the diagnosis, monitoring of disease progression and evaluation of therapeutic outcomes in patients with multiple sclerosis. Despite the advantages of the oculomotor assessment, standard clinical practices are limited and do not capture the dynamic aspects of eye-movement. Sophisticated methods have been developed in the laboratory […]
Read More